Na/K-ATPase/src complex mediates regulation of CD40 in renal parenchyma
Authors:
- 22 December 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (7) , 1138-1149
Abstract
Background. Recent studies have highlighted a critical role for CD40 in the pathogenesis of renal injury and fibrosis. However, little is currently understood about the regulation of CD40 in this setting. Methods. We use novel Na/K-ATPase cell lines and inhibitors in order to demonstrate the regulatory function of Na/K-ATPase with regards to CD40 expression and function. We utilize 5/6 partial nephrectomy as well as direct infusion of a Na/K-ATPase ligand to demonstrate this mechanism exists in vivo. Results. We demonstrate that knockdown of the alpha 1 isoform of Na/K-ATPase causes a reduction in CD40 while rescue of the alpha 1 but not the alpha 2 isoform restores CD40 expression in renal epithelial cells. Second, because the major functional difference between alpha 1 and alpha 2 is the ability of alpha 1 to form a functional signaling complex with Src, we examined whether the Na/KATPase/Src complex is important for CD40 expression. We show that a gain-of-Src binding alpha 2 mutant restores CD40 expression while loss-of-Src binding alpha 1 reduces CD40 expression. Furthermore, loss of a functional Na/K-ATPase/Src complex also disrupts CD40 signaling. Importantly, we show that use of a specific Na/K-ATPase/Src complex antagonist, pNaKtide, can attenuate cardiotonic steroid (CTS)-induced induction of CD40 expression in vitro. Conclusions. Because the Na/K-ATPase/Src complex is also a key player in the pathogenesis of renal injury and fibrosis, our new findings suggest that Na/K-ATPase and CD40 may comprise a pro-fibrotic feed-forward loop in the kidney and that pharmacological inhibition of this loop may be useful in the treatment of renal fibrosis.Keywords
Funding Information
- American Heart Association (13POST16860035, 12SDG12050473)
- National Institutes of Health (1RO1HL105649, 1RO1HL137004)
- David and Helen Boone Foundation Research Fund
- Central Society for Clinical and Translational Research
- University of Toledo Women and Philanthropy Genetic Analysis Instrumentation Center
This publication has 50 references indexed in Scilit:
- SH2 Ligand-Like Effects of Second Cytosolic Domain of Na/K-ATPase α1 Subunit on Src KinasePLOS ONE, 2015
- Expression of rat Na-K-ATPase α2 enables ion pumping but not ouabain-induced signaling in α1-deficient porcine renal epithelial cellsAmerican Journal of Physiology-Cell Physiology, 2015
- Passive Immunization Against Marinobufagenin Attenuates Renal Fibrosis and Improves Renal Function in Experimental Renal DiseaseAmerican Journal of Hypertension, 2013
- CD36 and Na/K-ATPase-α1 Form a Proinflammatory Signaling Loop in KidneyHypertension, 2013
- Spironolactone Attenuates Experimental Uremic Cardiomyopathy by Antagonizing MarinobufageninHypertension, 2009
- NaKtide, a Na/K-ATPase-derived Peptide Src Inhibitor, Antagonizes Ouabain-activated Signal Transduction in Cultured CellsJournal of Biological Chemistry, 2009
- Low Doses of Ouabain Protect from Serum Deprivation–Triggered Apoptosis and Stimulate Kidney Cell Proliferation via Activation of NF-κBJournal of the American Society of Nephrology, 2006
- Functional Characterization of Src-interacting Na/K-ATPase Using RNA Interference AssayJournal of Biological Chemistry, 2006
- CD40-mediated activation of vascular smooth muscle cell chemokine production through a Src-initiated, MAPK-dependent pathwayCellular Signalling, 2004
- Reactive Oxygen Species and Matrix Remodeling in Diabetic KidneyJournal of the American Society of Nephrology, 2003